secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0000950170-25-001712
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics appoints Juan Graham as CFO; Jonathan Hunt remains CAO
-------------------------------------------------------------------------------

- Juan Graham appointed CFO effective Jan 6, 2025; Jonathan Hunt steps down as CFO but stays CAO.
- Graham brings 25 years experience; previously CFO of FibroGen, finance leadership at Johnson & Johnson.
- Annual base salary $500k, target bonus 40%, signing bonus $80k, option grant of 400k shares with 4-year vest.
- Severance: 12 months salary plus pro-rated bonus and COBRA upon termination without cause or for good reason.
- Change of control: accelerated vesting of equity; severance of 12 months salary if not retained or termination within 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/catx-20250102.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-001712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer